Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 11/2017

Open Access 01-11-2017 | Original Paper

Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping

Authors: R. van Dijk, D. Kuijpers, T. A. M. Kaandorp, P. R. M. van Dijkman, R. Vliegenthart, P. van der Harst, M. Oudkerk

Published in: The International Journal of Cardiovascular Imaging | Issue 11/2017

Login to get access

Abstract

The antagonistic effects of caffeine on adenosine receptors are a possible cause of false-negative stress perfusion imaging. The purpose of this study was to determine the effects of coffee intake <4 h prior to stress perfusion cardiac magnetic resonance imaging (CMR) in regadenoson- versus adenosine-induced hyperemia as measured with T1-mapping. 98 consecutive patients with suspected coronary artery disease referred for either adenosine or regadenoson perfusion CMR were included in this analysis. Twenty-four patients reported coffee consumption <4 h before CMR (15 patients with adenosine, and 9 patients with regadenoson); 74 patients reported no coffee intake (50 patients with adenosine, and 24 patients with regadenoson). T1 mapping was performed using a modified look-locker inversion recovery sequence. T1 reactivity was determined by subtracting T1rest from T1stress. T1rest, T1stress, and T1 reactivity in patients referred for regadenoson perfusion CMR were not significantly different when comparing patients with <4 h coffee intake and patients who reported no coffee intake (976 ± 4 ms, 1019 ± 48 ms, and 4.4 ± 3.2% vs 971 ± 33 ms, 1023 ± 43 ms, and 5.4 ± 2.4%) (p = 0.70, 0.79, and 0.40), and similar to values in patients without coffee intake undergoing adenosine CMR. In patients with <4 h coffee intake, T1stress, and T1 reactivity were significantly lower for adenosine (898 ± 51 ms, and −7.8 ± 5.0%) compared to regadenoson perfusion CMR (p < 0.001). Coffee intake <4 h prior to regadenoson perfusion CMR has no effect on stress-induced hyperemia as measured with T1 mapping.
Literature
1.
go back to reference Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Uva MS, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2015) 2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol 68(2):144 (Engl Ed) Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Uva MS, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2015) 2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol 68(2):144 (Engl Ed)
2.
go back to reference Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schönberg SO, Debl K, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T (2012) Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: the secondary endpoints of the multicenter multivendor MR-IMPACT II (magnetic resonance imaging for myocardial perfusion assessment in Coronary Artery Disease Trial). J Cardiovasc Magn Res 14:61–71CrossRef Schwitter J, Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schönberg SO, Debl K, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T (2012) Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: the secondary endpoints of the multicenter multivendor MR-IMPACT II (magnetic resonance imaging for myocardial perfusion assessment in Coronary Artery Disease Trial). J Cardiovasc Magn Res 14:61–71CrossRef
3.
go back to reference Fredholm BB, Irenius E, Kull B (2001) Comparison of the potency of adenosine as an antagonist at human adenosine receptors expressed in Chines hamster ovary cells. Biochem Pharmacol 61:443–448CrossRefPubMed Fredholm BB, Irenius E, Kull B (2001) Comparison of the potency of adenosine as an antagonist at human adenosine receptors expressed in Chines hamster ovary cells. Biochem Pharmacol 61:443–448CrossRefPubMed
4.
go back to reference Ribeiro J, Sebastastião AM (2010) Caffeine and adenosine. J Alzheimer’s Dis 20:S3–S15CrossRef Ribeiro J, Sebastastião AM (2010) Caffeine and adenosine. J Alzheimer’s Dis 20:S3–S15CrossRef
5.
go back to reference Trochu JN, Zhao G, Post H (2003) Selective A-2a receptor agonist as a coronary vasodilatator in conscious dogs: potential for use in myocardial perfusion imaging. J Cardiovasc Pharmacol 41:132–139CrossRefPubMed Trochu JN, Zhao G, Post H (2003) Selective A-2a receptor agonist as a coronary vasodilatator in conscious dogs: potential for use in myocardial perfusion imaging. J Cardiovasc Pharmacol 41:132–139CrossRefPubMed
6.
go back to reference Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo JA, Blackburn B, Mahmarian JJ (2005) Initial clinical experience with regadenoson, a novel selective A 2 A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 46(11):2069–2075CrossRefPubMed Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo JA, Blackburn B, Mahmarian JJ (2005) Initial clinical experience with regadenoson, a novel selective A 2 A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 46(11):2069–2075CrossRefPubMed
7.
go back to reference Johnson SG, Peters S (2010) Advances in pharmacologic stress agents: focus on regadenoson. J Nucl Med Technol 38(3):163–171CrossRefPubMed Johnson SG, Peters S (2010) Advances in pharmacologic stress agents: focus on regadenoson. J Nucl Med Technol 38(3):163–171CrossRefPubMed
8.
go back to reference Plein S, Kidambi A, Sourbon S, Maredia N, Uddin A, Motwani M, Ripley DP, Herzog BA, Brown J, Nixon J, Everett C, Greenwood JP (2013) Associated factors for a false negative cardiovascular magnetic resonance perfusion study: a CE-MARC substudy. J Cardiovasc Magn Reson 15(Suppl 1):P214CrossRefPubMedCentral Plein S, Kidambi A, Sourbon S, Maredia N, Uddin A, Motwani M, Ripley DP, Herzog BA, Brown J, Nixon J, Everett C, Greenwood JP (2013) Associated factors for a false negative cardiovascular magnetic resonance perfusion study: a CE-MARC substudy. J Cardiovasc Magn Reson 15(Suppl 1):P214CrossRefPubMedCentral
9.
go back to reference Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, Nixon J et al (2016) Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: a clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging 43(3):566–573CrossRefPubMed Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, Nixon J et al (2016) Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: a clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging 43(3):566–573CrossRefPubMed
10.
go back to reference Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance and sin-gle-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379(9814):453–460CrossRefPubMedPubMedCentral Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance and sin-gle-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379(9814):453–460CrossRefPubMedPubMedCentral
11.
go back to reference Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92CrossRefPubMedPubMedCentral Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, Gatehouse PD, Arai AE, Friedrich MG, Neubauer S, Schulz-Menger J, Schelbert EB (2013) Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 15:92CrossRefPubMedPubMedCentral
12.
go back to reference Liu A, Wijesurendra RS, Francis JM, Robson MD, Neubauer S, Piechnik SK, ferreira VM (2016) Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast agents. J Am Coll Cardiol 9:27–36CrossRef Liu A, Wijesurendra RS, Francis JM, Robson MD, Neubauer S, Piechnik SK, ferreira VM (2016) Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast agents. J Am Coll Cardiol 9:27–36CrossRef
13.
go back to reference Kuijpers D, Prakken NH, Vliegenthart R, van Dijkman PRM, van der Harst P, Oudkerk M (2016) Caffeine intake inverts the effect of adenosine on myocardial perfusion during stress as measured with T1 mapping. Int J Cardiovasc Imaging 32(10):1545–1553CrossRefPubMedPubMedCentral Kuijpers D, Prakken NH, Vliegenthart R, van Dijkman PRM, van der Harst P, Oudkerk M (2016) Caffeine intake inverts the effect of adenosine on myocardial perfusion during stress as measured with T1 mapping. Int J Cardiovasc Imaging 32(10):1545–1553CrossRefPubMedPubMedCentral
14.
go back to reference Lubbers DD, Rijlaarsdam-Hermsen D, Kuijpers D, Kerkhof M, Sijens PE, van Dijkman PRM, Oudkerk M (2012) Performance of adenosine “stress-only” perfusion MRI in patients without a history of myocardial infarction: a clinical outcome study. Int J Cardiovasc Imaging 28(1):109–115CrossRefPubMed Lubbers DD, Rijlaarsdam-Hermsen D, Kuijpers D, Kerkhof M, Sijens PE, van Dijkman PRM, Oudkerk M (2012) Performance of adenosine “stress-only” perfusion MRI in patients without a history of myocardial infarction: a clinical outcome study. Int J Cardiovasc Imaging 28(1):109–115CrossRefPubMed
15.
go back to reference Child N, Yap ML, Dabir S, Rogers T, Suna G, Sandhu B, Higgins DM, Mayr M, Nagel E, Puntmann VO (2015) T1 values by conservative septal post-processing approach are superior in relating to the interstitial myocardial fibrosis: findings from patients with severe aortic stenosis. J Cardiovasc Magn Reson 17(S1):49CrossRef Child N, Yap ML, Dabir S, Rogers T, Suna G, Sandhu B, Higgins DM, Mayr M, Nagel E, Puntmann VO (2015) T1 values by conservative septal post-processing approach are superior in relating to the interstitial myocardial fibrosis: findings from patients with severe aortic stenosis. J Cardiovasc Magn Reson 17(S1):49CrossRef
16.
go back to reference Gaemperli O, Schepis T, Koepfli P, Siegrist PT, Fleischman S, Nguyen P, Kaufmann PA (2008) Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography. A randomized, double-blind, placebo-controlled crossover trial. J Am Coll Cardiol 51(3):328–329CrossRefPubMed Gaemperli O, Schepis T, Koepfli P, Siegrist PT, Fleischman S, Nguyen P, Kaufmann PA (2008) Interaction of caffeine with regadenoson-induced hyperemic myocardial blood flow as measured by positron emission tomography. A randomized, double-blind, placebo-controlled crossover trial. J Am Coll Cardiol 51(3):328–329CrossRefPubMed
17.
go back to reference Tejani FH, Thompson RC, Kristy R, Bukofzer S (2014) Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologis stress: a prospective, randomized, multicenter study. Int J Cardiovasc Imaging 30:979–989CrossRefPubMedPubMedCentral Tejani FH, Thompson RC, Kristy R, Bukofzer S (2014) Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologis stress: a prospective, randomized, multicenter study. Int J Cardiovasc Imaging 30:979–989CrossRefPubMedPubMedCentral
18.
go back to reference Cheng WS, Murphy TL, Smith MT, Cooksley WG, Halliday JW, Powell LW (1990) Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function. Clin Pharmacol Ther 47(4):516–524CrossRefPubMed Cheng WS, Murphy TL, Smith MT, Cooksley WG, Halliday JW, Powell LW (1990) Dose-dependent pharmacokinetics of caffeine in humans: relevance as a test of quantitative liver function. Clin Pharmacol Ther 47(4):516–524CrossRefPubMed
19.
go back to reference Reyes E (2016) Caffeine does not significantly reduce the sensitivity of vasodilator stress MPI: Rebuttal. J Nucl Cardiol 23(3):604CrossRefPubMed Reyes E (2016) Caffeine does not significantly reduce the sensitivity of vasodilator stress MPI: Rebuttal. J Nucl Cardiol 23(3):604CrossRefPubMed
20.
go back to reference Yang JN, Tiseluis C, Daré E, Johansson B, Valen G, Fredholm BB (2007) Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A 1 receptors. Acta Physiol 190:63–75CrossRef Yang JN, Tiseluis C, Daré E, Johansson B, Valen G, Fredholm BB (2007) Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A 1 receptors. Acta Physiol 190:63–75CrossRef
23.
go back to reference Bichler A, Swenson A, Harris MA (2006) A combination of caffeine and taurine has no effect on short term memory but induces changes in heart rate and mean arterial blood pressure. Amino Acids 31(4):471–476CrossRefPubMed Bichler A, Swenson A, Harris MA (2006) A combination of caffeine and taurine has no effect on short term memory but induces changes in heart rate and mean arterial blood pressure. Amino Acids 31(4):471–476CrossRefPubMed
Metadata
Title
Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
Authors
R. van Dijk
D. Kuijpers
T. A. M. Kaandorp
P. R. M. van Dijkman
R. Vliegenthart
P. van der Harst
M. Oudkerk
Publication date
01-11-2017
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 11/2017
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-017-1157-4

Other articles of this Issue 11/2017

The International Journal of Cardiovascular Imaging 11/2017 Go to the issue